Thursday, October 22, 2020 11:32:46 AM
Pevion's virus-like particle (VLP) vaccine technology, called virosomes, and its architecture is specifically designed to produce safe and efficient vaccine subunits. Virosome-based vaccination is effective in reliable regulatory and safety records as well as the feasibility of upgrading production and has been approved in more than 40 countries, including infants and older people. The prospect of drug delivery and targeting using virosomes is a vital area of research and development. This review pinpoints the various aspect of virosome and will be a milestone for the researchers in the field of drug delivery.
That from 2nd link
Volume 11 Issue 4
DOI: https://doi.org/10.26452/ijrps.v11i4
Published: Oct 7, 2020
Original Articles
https://pharmascope.org/ijrps/issue/view/48
ArticleHistory:Receivedon:03Jun2020Revisedon:05Jul2020Acceptedon:06Jul2020
https://pharmascope.org/ijrps/article/view/3230/7179
CONCLUSION
The virosomal drug delivery system is an intelli-gentapproachfortargeteddeliveryofdrugsandseveralotherbiologicallyactivemolecules,partic-ularly nucleic acids or genes. The main motivebehind the development of virosomal techniqueis to overcome the limitation of inadequate drugdeliverytowardstargetedcells,tissuesandorgansof the body. Virosomes are biodegradable, non-5818©InternationalJournalofResearchinPharmaceuticalSciences
SreejaCNairetal.,Int.J.Res.Pharm.Sci.,2020,11(4),5809-5820poisonous, biocompatible and non-auto immuno-genicunilamellarphospholipidbilayervesiclesthatcompriseproteinsderivedfromviruses. Antigenscan be delivered to the host body using variousroutesofadministrationlikeintradermal,intramus-cular and intranasal route, depending upon theaim of immunisation. Virosomes are consideredasaneffectiveprophylacticandtherapeuticagentdue to their added advantage of tissue targetingimmuneactivation&potentiationoverothertar-geteddrugdeliverysystems. Hence, theycanbewidelyusedinthe?ieldofcancertherapyasacar-rierforimmunomodulatingmoleculesaswellasfortargeteddrugs.ApplicationofVirosomeinthe?ieldoftargeteddrugdeliverysystemwillbringanewopportunity&alsoopenanewerainthemodernpharmaceuticalsector&humanlifetoo.
That from 2nd link
Volume 11 Issue 4
DOI: https://doi.org/10.26452/ijrps.v11i4
Published: Oct 7, 2020
Original Articles
https://pharmascope.org/ijrps/issue/view/48
ArticleHistory:Receivedon:03Jun2020Revisedon:05Jul2020Acceptedon:06Jul2020
https://pharmascope.org/ijrps/article/view/3230/7179
CONCLUSION
The virosomal drug delivery system is an intelli-gentapproachfortargeteddeliveryofdrugsandseveralotherbiologicallyactivemolecules,partic-ularly nucleic acids or genes. The main motivebehind the development of virosomal techniqueis to overcome the limitation of inadequate drugdeliverytowardstargetedcells,tissuesandorgansof the body. Virosomes are biodegradable, non-5818©InternationalJournalofResearchinPharmaceuticalSciences
SreejaCNairetal.,Int.J.Res.Pharm.Sci.,2020,11(4),5809-5820poisonous, biocompatible and non-auto immuno-genicunilamellarphospholipidbilayervesiclesthatcompriseproteinsderivedfromviruses. Antigenscan be delivered to the host body using variousroutesofadministrationlikeintradermal,intramus-cular and intranasal route, depending upon theaim of immunisation. Virosomes are consideredasaneffectiveprophylacticandtherapeuticagentdue to their added advantage of tissue targetingimmuneactivation&potentiationoverothertar-geteddrugdeliverysystems. Hence, theycanbewidelyusedinthe?ieldofcancertherapyasacar-rierforimmunomodulatingmoleculesaswellasfortargeteddrugs.ApplicationofVirosomeinthe?ieldoftargeteddrugdeliverysystemwillbringanewopportunity&alsoopenanewerainthemodernpharmaceuticalsector&humanlifetoo.
